Racial differences in treatment and survival in older patients with diffuse large B-cell lymphoma (DLBCL)
<p style="text-align:justify;"> <b>Background:</b> Diffuse large B-cell lymphoma (DLBCL) comprises 31% of lymphomas in the United States. Although it is an aggressive type of lymphoma, 40% to 50% of patients are cured with treatment. The study objectives were to identify...
Hlavní autoři: | , , , |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
BioMed Central
2010
|